TechnologyPatent OppositionCompetitive Analysis

In the competitive field of Material Property Testing, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Material Property Testing technology and learn how to protect your intellectual property.

Get Patent Opposition Report for Material Property Testing

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Industry Landscape Report

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the Material Property Testing industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Material Property Testing industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Jul 31, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Material Property Testing industry

Contoured Sample Path For Fluid AnalyzerSIEMENS HEALTHCARE DIAGNOSTICSJun 25, 2025RADIOMETER
Anti-Pd-1 And Anti-Vegfa Bifunctional Antibody, Pharmaceutical Composition Thereof And Use ThereofAKESO BIOPHARMAJun 18, 2025STRAWMAN
Measuring Arrangement And Method For Optically Testing Articles Of The Tobacco Processing IndustryKRBERJun 18, 2025GD
Interleukin-31 Monoclonal AntibodyZOETIS SERVICESJun 16, 2025MARGARET DIXON
Interleukin-31 Monoclonal AntibodyZOETIS SERVICESJun 13, 2025BOEHRINGER INGELHEIM VETMEDICA
Enantiomers Of Tetrahydro-N,N-Dimethyl-2,2-Diphenyl-3-Furanmethanamine (Anavex2-73) And Use Thereof In The Treatment Of Alzheimer'S Disease And Other Disorders Modulated By The Sigma 1 ReceptorANAVEX LIFE SCIENCESJun 12, 2025ELKINGTON AND FIFE
Methods Of Purifying PolypeptidesF HOFFMANN LA ROCHEMay 28, 2025MESTER
Sorting With Counter Selection Using Sequence Similar PeptidesIMMATICSMay 28, 2025STRAWMAN
Sensor Positioning Device And SensorEXNER & TOTTEWITZ BESITZ GBRMay 28, 2025SCHOTT
Methods Of Purifying PolypeptidesF HOFFMANN LA ROCHEMay 27, 2025ZWICKER SCHNAPPAUF & PARTNER PATENTANWALTE PARTG MBB

To stay ahead in the competitive Material Property Testing industry, companies are constantly innovating. Here are the top patents facing oppositions in the Material Property Testing industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Jul 31, 2025
Patent NumberGrant DateTitleApplicantTotal Oppositions
Aug 24, 2022Compositions And Uses For Treating Multiple SclerosisBIOGEN IDEC MA14
Sep 19, 2018Methods Of Cell CultureMOMENTA PHARMACEUTICALS10
Jan 13, 2021Method Of Treating Cancer Using Immune Checkpoint InhibitorBRISTOL MYERS SQUIBB9
Apr 24, 2024Methods For Treating Atopic Dermatitis By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGY7
Mar 28, 2018Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules RepeatedlyCHUGAI SEIYAKU KABUSHIKI KAISHA6
Mar 21, 2018Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules RepeatedlyCHUGAI SEIYAKU KABUSHIKI KAISHA5
Oct 4, 2023Il-17 A/F Heterologous Polypeptides And Therapeutics Uses ThereofGENENTECH5
Jan 10, 2024Improved Protocol For Treatment Of Lupus NephritisAURINIA PHARMACEUTICALS5
Dec 21, 2022Identifying Patient Response To S1P Receptor Modulator AdministrationNOVARTIS4
Apr 29, 2020Composition For Inducing Proliferation Or Accumulation Of Regulatory T CellsTHE UNIVERSITY OF TOKYO4